Our Scientific Advisory Board includes thought leaders in the cancer research and therapeutics field. The willingness and enthusiasm from each of our SAB members to participate on this board further validates our therapeutic approach. Rigorous discussions and input will strengthen our product platform research and development. Members of our SAB include:
Geoffrey Smith, PhD | University of Cambridge |
David Bartlett, MD | University Pittsburgh Medical Center |
Grant McFadden, PhD | University of Florida, College of Medicine |
Frank McCormick, PhD | University of California, San Francisco Helen Diller Family Comprehensive Cancer Center |
Ramesh Shivdasani, MD, PhD | Dana Farber Cancer Institute |
Paul Polakis, PhD | Genentech |
Terry Hermiston, PhD | Bayer HealthCare Pharmaceuticals |
Malcolm Brenner, MD, PhD | Baylor College of Medicine |
Douglas Hanahan, PhD | University of California, San Francisco |
Drew Pardoll, MD, PhD | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
We work closely with a group of experts in the liver cancer field in order for us to have the most up-to-date picture of the liver cancer market as we pursue the development of our lead product, JX-594, for liver cancer. We have strong representation from both North America and Asia on this board, and the members include:
Ghassan K. Abou-Alfa, MD | Memorial Sloan-Kettering Cancer Center |
Ann Lii Cheng, MD, PhD | National Taiwan University Hospital |
Mong Cho, MD | Pusan National University |
Hyun C Chung, MD, PhD | Yonsei University, Korea. |
Jean Francois Geschwind, MD | Johns Hopkins University |
Jeong Heo, MD, PhD | Pusan National University Hospital |
Daniel Sze, MD, PhD | Stanford University |
John E.L. Wong, MBBS, FAMS, FRCP, FACP |
Yong Loo Lin School of Medicine at the National University of Singapore |
Riccardo Lencioni, MD | Pisa University Hospital in Italy, Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation |
Richard Goldberg, MD | Ohio State University |
Leonard Saltz, MD | Memorial Sloan-Kettering Cancer Center |